Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
about
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineEffects of Pirfenidone and Collagen-Polyvinylpyrrolidone on Macroscopic and Microscopic Changes, TGF-β1 Expression, and Collagen Deposition in an Experimental Model of Tracheal Wound Healing.Obligatory role for interleukin-13 in obstructive lesion development in airway allografts.Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.Targeting the TGFβ signalling pathway in disease.Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation.Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model.Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia.Immunosuppression in lung transplantation.Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Pirfenidone for the treatment of idiopathic pulmonary fibrosis.Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.Transforming growth factor-β in stem cells and tissue homeostasis.
P2860
Q26777928-4A164CD8-CE5D-4A25-92A9-12181234BAF7Q33726417-8DCAB2BD-2C9C-4114-933D-97FD569FA899Q35221878-A28BA44C-79C9-40E8-8D92-71F6BA6E2A3EQ36330564-5BD7C76C-4A8B-4AE4-967F-9D6FBC6883D8Q36462348-8BE9A7EB-D834-42A1-BA73-5626E81EEE04Q36754289-7E37598F-5A44-468E-93FB-47A2144DA733Q37085651-F5399C79-80C6-4D92-AEFE-631C4D1576C0Q37305376-1850650B-D986-4D46-9038-90D7B0263005Q37520369-77555FAE-6433-414F-A603-3984CC0F322DQ38240865-93705C36-B741-45DE-A471-183E54EDD74EQ38932342-44903FE5-5E62-4AC7-821F-CD228A0D7413Q39165575-815CBDFC-4809-4178-A8D7-AE925612A7A4Q42246110-BAF3370F-CBCE-45D3-8579-63CB4CC9199CQ50104779-59660217-0173-4D8C-9E64-A7C009ED9541
P2860
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@ast
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@en
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@nl
type
label
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@ast
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@en
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@nl
prefLabel
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@ast
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@en
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@nl
P2093
P1476
Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
@en
P2093
Christopher W Latham
Dani S Zander
Gary A Visner
Hailan Zhou
Solomon B Margolin
P304
P356
10.1016/J.HEALUN.2004.11.002
P577
2005-10-01T00:00:00Z